2023 Q2 Form 10-K Financial Statement

#000162828023024860 Filed on July 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 2022
Revenue $29.91M $123.7M $127.6M
YoY Change -13.67% -3.05% 14.49%
Cost Of Revenue $11.93M $49.37M $51.76M
YoY Change -8.86% -4.62% 2.64%
Gross Profit $17.98M $74.29M $75.80M
YoY Change -16.59% -1.98% 24.29%
Gross Profit Margin 60.11% 60.08% 59.42%
Selling, General & Admin $11.14M $45.87M $44.83M
YoY Change -5.2% 2.32% 13.65%
% of Gross Profit 61.95% 61.74% 59.14%
Research & Development $4.547M $17.77M $17.60M
YoY Change 5.84% 0.95% 3.75%
% of Gross Profit 25.29% 23.92% 23.22%
Depreciation & Amortization $25.00K $106.0K $4.138M
YoY Change -97.42% -97.44% -26.24%
% of Gross Profit 0.14% 0.14% 5.46%
Operating Expenses $15.71M $63.74M $62.64M
YoY Change -2.41% 1.76% 10.63%
Operating Profit $2.270M $10.55M $13.16M
YoY Change -58.4% -19.81% 201.67%
Interest Expense $1.028M $2.336M $391.0K
YoY Change 888.46% 497.44% -4.4%
% of Operating Profit 45.29% 22.14% 2.97%
Other Income/Expense, Net $153.0K $187.0K $290.0K
YoY Change -117.35% -35.52% -92.89%
Pretax Income $3.298M $12.89M $13.84M
YoY Change -29.51% -6.87% 56.39%
Income Tax $431.0K $2.465M $1.055M
% Of Pretax Income 13.07% 19.13% 7.62%
Net Earnings $2.867M $10.42M $12.78M
YoY Change -19.94% -18.47% 58.02%
Net Earnings / Revenue 9.58% 8.43% 10.02%
Basic Earnings Per Share $0.31 $0.38
Diluted Earnings Per Share $0.08 $0.31 $0.37
COMMON SHARES
Basic Shares Outstanding 33.76M shares 33.37M shares
Diluted Shares Outstanding 33.99M shares 34.31M shares

Balance Sheet

Concept 2023 Q2 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $115.1M $115.1M $127.5M
YoY Change -9.78% -9.78% 21.83%
Cash & Equivalents $91.60M $91.60M $110.7M
Short-Term Investments $23.45M $23.45M $16.83M
Other Short-Term Assets $7.081M $7.081M $5.067M
YoY Change 39.75% 39.75% -4.76%
Inventory
Prepaid Expenses
Receivables $28.01M $28.01M $23.61M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $150.1M $150.1M $156.2M
YoY Change -3.87% -3.87% 14.32%
LONG-TERM ASSETS
Property, Plant & Equipment $6.886M $6.886M $4.589M
YoY Change 88.45% 50.05% -6.0%
Goodwill $29.56M
YoY Change 14.18%
Intangibles $2.143M
YoY Change 1357.82%
Long-Term Investments $486.0K $486.0K
YoY Change
Other Assets $6.344M $6.344M $4.434M
YoY Change 166.11% 43.08% -4.38%
Total Long-Term Assets $45.81M $45.81M $36.64M
YoY Change 25.01% 25.01% -9.6%
TOTAL ASSETS
Total Short-Term Assets $150.1M $150.1M $156.2M
Total Long-Term Assets $45.81M $45.81M $36.64M
Total Assets $195.9M $195.9M $192.8M
YoY Change 1.61% 1.61% 8.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.427M $2.427M $2.506M
YoY Change -3.15% -3.15% 44.69%
Accrued Expenses $4.692M $4.692M $7.459M
YoY Change -37.1% -37.1% 8.61%
Deferred Revenue $43.12M
YoY Change 2.79%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $56.33M $56.33M $57.49M
YoY Change -2.02% -2.02% 13.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $288.0K $288.0K $598.0K
YoY Change 110.22% -51.84% -59.46%
Total Long-Term Liabilities $288.0K $288.0K $598.0K
YoY Change 110.22% -51.84% -59.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.33M $56.33M $57.49M
Total Long-Term Liabilities $288.0K $288.0K $598.0K
Total Liabilities $56.62M $56.62M $59.86M
YoY Change -5.42% -5.42% 9.3%
SHAREHOLDERS EQUITY
Retained Earnings -$21.70M
YoY Change 25.91%
Common Stock $182.7M
YoY Change 6.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $139.3M $139.3M $133.0M
YoY Change
Total Liabilities & Shareholders Equity $195.9M $195.9M $192.8M
YoY Change 1.61% 1.61% 8.85%

Cashflow Statement

Concept 2023 Q2 2023 2022
OPERATING ACTIVITIES
Net Income $2.867M $10.42M $12.78M
YoY Change -19.94% -18.47% 58.02%
Depreciation, Depletion And Amortization $25.00K $106.0K $4.138M
YoY Change -97.42% -97.44% -26.24%
Cash From Operating Activities $10.09M -$380.0K $29.02M
YoY Change -32.63% -101.31% 63.44%
INVESTING ACTIVITIES
Capital Expenditures $267.0K $3.922M $970.0K
YoY Change -300.75% 304.33% 43.07%
Acquisitions $6.500M $0.00
YoY Change
Other Investing Activities $0.00 -$6.500M
YoY Change
Cash From Investing Activities -$267.0K -$10.42M -$934.0K
YoY Change 100.75% 1015.85% -28.04%
FINANCING ACTIVITIES
Cash Dividend Paid $14.83M $14.63M
YoY Change 1.37% 2.24%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 271.0K -9.192M -$6.054M
YoY Change -110.83% 51.83% -20.49%
NET CHANGE
Cash From Operating Activities 10.09M -380.0K $29.02M
Cash From Investing Activities -267.0K -10.42M -$934.0K
Cash From Financing Activities 271.0K -9.192M -$6.054M
Net Change In Cash 10.09M -19.99M $22.03M
YoY Change -18.2% -190.75% 149.12%
FREE CASH FLOW
Cash From Operating Activities $10.09M -$380.0K $29.02M
Capital Expenditures $267.0K $3.922M $970.0K
Free Cash Flow $9.819M -$4.302M $28.05M
YoY Change -34.99% -115.34% 64.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000713425
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2023 dei Security12g Title
Security12gTitle
Class A Common Shares
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
577900000 usd
CY2023 dei Auditor Name
AuditorName
KPMG LLP
CY2023 dei Auditor Location
AuditorLocation
Atlanta, GA
CY2023 dei Auditor Firm
AuditorFirmId
185
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90696000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110690000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
23451000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
16826000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
418000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
423000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25405000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20619000 usd
CY2023Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2604000 usd
CY2022Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2989000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7833000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5067000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
149989000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
156191000 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
486000 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6444000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3654000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1772000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
288000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
598000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
56286000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
59859000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
182722000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
171948000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21702000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17236000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4588632 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4588632 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25559000 usd
CY2022Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25559000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
139334000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
132976000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195620000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
192835000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127553000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
51758000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50428000 usd
CY2022 us-gaap Gross Profit
GrossProfit
75795000 usd
CY2021 us-gaap Gross Profit
GrossProfit
60980000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17600000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16964000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22867000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20304000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21960000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19139000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
212000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
212000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
62639000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
56619000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
13156000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
4361000 usd
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
391000 usd
CY2021 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
409000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
290000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4078000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13837000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8848000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1055000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
759000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
10421000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12782000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8089000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33761000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33365000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32559000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33992000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34305000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33169000 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
119422000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6697000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2546000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8089000 usd
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
14363000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
122391000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8578000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3956000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12782000 usd
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
14731000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
132976000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5641000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5183000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
10421000 usd
CY2023 us-gaap Dividends Common Stock
DividendsCommonStock
14887000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
139334000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
10421000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12782000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8089000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3161000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4138000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5610000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5183000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3956000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2546000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
133000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
394000 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
3569000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
36000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4092000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-854000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-270000 usd
CY2023 amswa Payments To Acquire Securities Trading
PaymentsToAcquireSecuritiesTrading
8599000 usd
CY2022 amswa Payments To Acquire Securities Trading
PaymentsToAcquireSecuritiesTrading
1713000 usd
CY2021 amswa Payments To Acquire Securities Trading
PaymentsToAcquireSecuritiesTrading
1294000 usd
CY2023 amswa Proceeds From Sale And Maturityof Securities Trading
ProceedsFromSaleAndMaturityofSecuritiesTrading
1620000 usd
CY2022 amswa Proceeds From Sale And Maturityof Securities Trading
ProceedsFromSaleAndMaturityofSecuritiesTrading
1287000 usd
CY2021 amswa Proceeds From Sale And Maturityof Securities Trading
ProceedsFromSaleAndMaturityofSecuritiesTrading
3718000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4401000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3031000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1632000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2088000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-450000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-845000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2623000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1562000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
799000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1171000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4811000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2914000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-380000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29020000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17756000 usd
CY2023 amswa Payments To Develop Software To Be Sold Leased Or Otherwise Marketed
PaymentsToDevelopSoftwareToBeSoldLeasedOrOtherwiseMarketed
0 usd
CY2022 amswa Payments To Develop Software To Be Sold Leased Or Otherwise Marketed
PaymentsToDevelopSoftwareToBeSoldLeasedOrOtherwiseMarketed
0 usd
CY2021 amswa Payments To Develop Software To Be Sold Leased Or Otherwise Marketed
PaymentsToDevelopSoftwareToBeSoldLeasedOrOtherwiseMarketed
620000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3922000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
934000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
678000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6500000 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10422000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-934000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1298000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5641000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8578000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6697000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
14833000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
14632000 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
14311000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9192000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6054000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7614000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19994000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22032000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8844000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110690000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88658000 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79814000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90696000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110690000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88658000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8511000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
300000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
518000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
3756000 usd
CY2022Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
3700000 usd
CY2021Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
3615000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023 amswa Number Of Major Product And Service Groups
NumberOfMajorProductAndServiceGroups
6 group
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023 amswa Revenue From Contracts With Customer Excluding Assessed Tax Reimbursements Recognized As Revenue
RevenueFromContractsWithCustomerExcludingAssessedTaxReimbursementsRecognizedAsRevenue
328000 usd
CY2022 amswa Revenue From Contracts With Customer Excluding Assessed Tax Reimbursements Recognized As Revenue
RevenueFromContractsWithCustomerExcludingAssessedTaxReimbursementsRecognizedAsRevenue
171000 usd
CY2021 amswa Revenue From Contracts With Customer Excluding Assessed Tax Reimbursements Recognized As Revenue
RevenueFromContractsWithCustomerExcludingAssessedTaxReimbursementsRecognizedAsRevenue
26000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
41000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43124000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41953000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
124000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.52
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123659000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127553000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3000000 usd
CY2022Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3400000 usd
CY2023 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1700000 usd
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2100000 usd
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2000000 usd
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2021 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023Q2 amswa Unbilled License Fees
UnbilledLicenseFees
300000 usd
CY2022Q2 amswa Unbilled License Fees
UnbilledLicenseFees
1000000 usd
CY2023Q2 amswa Unbilled Services Revenue
UnbilledServicesRevenue
2300000 usd
CY2022Q2 amswa Unbilled Services Revenue
UnbilledServicesRevenue
2000000 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
81400000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
98500000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of Credit RiskFinancial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. The Company maintains cash and cash equivalents and short-term investments with various financial institutions. The Company’s sales are primarily to companies located in North America and Europe. The Company performs periodic credit evaluations of its clients’ financial condition and does not require collateral. Accounts receivable are due principally from companies under stated contract terms.
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1200000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
700000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
600000 usd
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2021 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
620000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17767000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17600000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16964000 usd
CY2023 amswa Research And Development Costs Including Software Development Costs
ResearchAndDevelopmentCostsIncludingSoftwareDevelopmentCosts
17767000 usd
CY2022 amswa Research And Development Costs Including Software Development Costs
ResearchAndDevelopmentCostsIncludingSoftwareDevelopmentCosts
17600000 usd
CY2021 amswa Research And Development Costs Including Software Development Costs
ResearchAndDevelopmentCostsIncludingSoftwareDevelopmentCosts
17584000 usd
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1195000 usd
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3181000 usd
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4215000 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
43593000 usd
CY2022Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
43593000 usd
CY2023Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
43202000 usd
CY2022Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
42007000 usd
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
391000 usd
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1586000 usd
CY2023 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2830000 usd
CY2023 amswa Intangible Assets Amortization Expense
IntangibleAssetsAmortizationExpense
834000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2143000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
25888000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
3670000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
29558000 usd
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
360000 usd
CY2022 amswa Intangible Assets Amortization Expense
IntangibleAssetsAmortizationExpense
213000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
147000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities, at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including, but not limited to, those related to revenue/reserves and allowances. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results could differ materially from these estimates under different assumptions or conditions.
CY2023 amswa Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
1 plan
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5200000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4000000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2500000 usd
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
70000 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1700000 usd
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
600000 usd
CY2023 amswa Convertible Stock Conversion Ratio
ConvertibleStockConversionRatio
1
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023 us-gaap Advertising Expense
AdvertisingExpense
2700000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
3000000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2100000 usd
CY2023 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
Guarantees and Indemnifications<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for guarantees in accordance with the Guarantee Topic of the FASB ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company’s sales agreements with clients generally contain infringement indemnity provisions. Under these agreements, the Company agrees to indemnify, defend and hold harmless the client in connection with intellectual property infringement claims made by third parties with respect to the client’s authorized use of the Company’s products and services. The indemnity provisions generally provide for the Company’s control of defense and settlement and cover costs and damages finally awarded against the client, as well as the Company’s modification of the product so it is no longer infringing or, if it cannot be corrected, return of the product for a refund. The sales agreements with clients sometimes also contain indemnity provisions for breach of confidentiality and death, personal injury or property damage caused by the Company’s personnel or contractors in the course of performing services to clients. Under these agreements, the Company agrees to indemnify, defend and hold harmless the client in connection with death, personal injury and property damage claims made by third parties and confidentiality breach claims with respect to actions of the Company’s personnel or contractors. The indemnity provisions generally provide for the Company’s control of defense and settlement and cover costs and damages finally awarded against the client. The indemnity obligations contained in sales agreements may have a limited monetary award. The Company has not previously incurred costs to settle claims or pay awards under these indemnification obligations. The Company accounts for these indemnity obligations in accordance with the Contingencies Topic of the FASB ASC and records a liability for these obligations when a loss is probable and reasonably estimable. The Company has not recorded any liabilities for these agreements as of April 30, 2023 or 2022.</span>The Company warrants to its clients that its software products will perform in all material respects in accordance with the standard specifications, generally for 90 days after delivery of the licensed products and for the subscription term for SaaS products. Additionally, the Company warrants to its clients that services will be performed consistent with generally accepted industry standards or specific service levels through completion of the agreed upon services. If necessary, the Company will provide for the estimated cost of product and service warranties based on specific warranty claims and claim history. However, the Company has not incurred significant recurring expense under product or service warranties.
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
0 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
0 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
7305000 usd
CY2022Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
0 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
16632000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
16826000 usd
CY2023Q2 us-gaap Trading Securities
TradingSecurities
23937000 usd
CY2022Q2 us-gaap Trading Securities
TradingSecurities
16826000 usd
CY2023Q2 us-gaap Investments
Investments
23900000 usd
CY2022Q2 us-gaap Investments
Investments
16800000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
81352000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
98459000 usd
CY2023Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
7305000 usd
CY2023Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
7305000 usd
CY2022Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
0 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
16632000 usd
CY2023Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
16632000 usd
CY2022Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
16826000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
105289000 usd
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
115285000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38815000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34894000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32371000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31240000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6444000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3654000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5205000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1294000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
693000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1352000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
615000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
386000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6557000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1909000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1079000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3666000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-712000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-238000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-426000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-142000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-82000 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-4092000 usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-854000 usd
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-320000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2465000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1055000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
759000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2691000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2905000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1858000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
601000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
396000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
323000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
586000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
522000 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
640000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-70000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1737000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-641000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
37000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
44000 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
1000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-134000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
57000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-140000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2465000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1055000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
759000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.076
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.086
CY2023 amswa Provision For Income Tax Realized From Stock Options Exercised
ProvisionForIncomeTaxRealizedFromStockOptionsExercised
83000 usd
CY2022 amswa Provision For Income Tax Realized From Stock Options Exercised
ProvisionForIncomeTaxRealizedFromStockOptionsExercised
2067000 usd
CY2021 amswa Provision For Income Tax Realized From Stock Options Exercised
ProvisionForIncomeTaxRealizedFromStockOptionsExercised
763000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
234000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
473000 usd
CY2023Q2 amswa Deferred Tax Assets Internal Revenue Service Costs
DeferredTaxAssetsInternalRevenueServiceCosts
3651000 usd
CY2022Q2 amswa Deferred Tax Assets Internal Revenue Service Costs
DeferredTaxAssetsInternalRevenueServiceCosts
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
13000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
49000 usd
CY2023Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
516000 usd
CY2022Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
823000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2676000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1740000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2860000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3873000 usd
CY2023Q2 amswa Deferred Tax Assets Operating Lease Right Of Use Liability
DeferredTaxAssetsOperatingLeaseRightOfUseLiability
117000 usd
CY2022Q2 amswa Deferred Tax Assets Operating Lease Right Of Use Liability
DeferredTaxAssetsOperatingLeaseRightOfUseLiability
251000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
83000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
83000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10150000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7292000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2861000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3891000 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7289000 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3401000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
96000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
396000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
2160000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1993000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1705000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1399000 usd
CY2023Q2 amswa Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
108000 usd
CY2022Q2 amswa Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
234000 usd
CY2023Q2 amswa Deferred Tax Liabilities Deferred Commission
DeferredTaxLiabilitiesDeferredCommission
900000 usd
CY2022Q2 amswa Deferred Tax Liabilities Deferred Commission
DeferredTaxLiabilitiesDeferredCommission
1151000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4969000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5173000 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2320000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1772000 usd
CY2023Q2 amswa Number Of Stock Option Plans
NumberOfStockOptionPlans
2 plan
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4540104 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.05
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1549000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.32
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
501547 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.25
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
163100 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.51
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
151400 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
15.36
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5273057 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.59
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
148083 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.47
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y6M
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
125643 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.37
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.86
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.87
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.027
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.017
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.027
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.428
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.413
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.383
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.033
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.003
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
501547 shares
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
776129 shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
628917 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10000000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4200000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4400000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2800000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2200000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
13400000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M14D
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
442000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
935000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
935000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
411000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
541000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
541000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
461000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
461000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
476000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1002000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
515000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
740000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
703000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
570000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
222000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
239000 usd
CY2023 us-gaap Lease Cost
LeaseCost
1440000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1549000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 usd
CY2023 amswa Number Of Leases Renewed
NumberOfLeasesRenewed
1 lease
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1600000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.031
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.032
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
417000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
67000 usd
CY2023Q2 amswa Lessee Operating Lease Liability Payments Due After Year Two
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
484000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
476000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
201000000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
102000000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
91000000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
96000000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
16000000 usd
CY2023Q2 amswa Lessor Operating Lease Payment To Be Received After Year Three
LessorOperatingLeasePaymentToBeReceivedAfterYearThree
0 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
506000000 usd
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
465000 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
477000 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
451000 usd
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
22500 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023Q2 amswa Number Of Supply Chain Process Areas
NumberOfSupplyChainProcessAreas
8 supplychain
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123659000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127553000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111408000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
10550000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
13156000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
4361000 usd
CY2023 amswa Payments To Acquire Property Plant And Equipment Including Gain Loss On Disposition Of Property Plant Equipment
PaymentsToAcquirePropertyPlantAndEquipmentIncludingGainLossOnDispositionOfPropertyPlantEquipment
4188000 usd
CY2022 amswa Payments To Acquire Property Plant And Equipment Including Gain Loss On Disposition Of Property Plant Equipment
PaymentsToAcquirePropertyPlantAndEquipmentIncludingGainLossOnDispositionOfPropertyPlantEquipment
970000 usd
CY2021 amswa Payments To Acquire Property Plant And Equipment Including Gain Loss On Disposition Of Property Plant Equipment
PaymentsToAcquirePropertyPlantAndEquipmentIncludingGainLossOnDispositionOfPropertyPlantEquipment
678000 usd
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2021 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
620000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3161000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4138000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5610000 usd
CY2023 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2149000 usd
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
391000 usd
CY2021 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
409000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12886000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13837000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8848000 usd
CY2023Q2 us-gaap Assets
Assets
195620000 usd
CY2022Q2 us-gaap Assets
Assets
192835000 usd

Files In Submission

Name View Source Status
0001628280-23-024860-index-headers.html Edgar Link pending
0001628280-23-024860-index.html Edgar Link pending
0001628280-23-024860.txt Edgar Link pending
0001628280-23-024860-xbrl.zip Edgar Link pending
amswa-20230430.htm Edgar Link pending
amswa-20230430.xsd Edgar Link pending
amswa-20230430ex211.htm Edgar Link pending
amswa-20230430ex231.htm Edgar Link pending
amswa-20230430ex311.htm Edgar Link pending
amswa-20230430ex312.htm Edgar Link pending
amswa-20230430ex321.htm Edgar Link pending
amswa-20230430_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
amswa-20230430_cal.xml Edgar Link unprocessable
amswa-20230430_def.xml Edgar Link unprocessable
amswa-20230430_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amswa-20230430_pre.xml Edgar Link unprocessable
amswa-20230430_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending